PortfoliosLab logo

Aurinia Pharmaceuticals Inc. (AUPH)

Equity · Currency in USD · Last updated Sep 23, 2022

Company Info

ISINCA05156V1022
CUSIP05156V102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$7.47
Year Range$6.66 - $33.08
EMA (50)$8.36
EMA (200)$13.08
Average Volume$2.52M
Market Capitalization$1.07B

AUPHShare Price Chart


Chart placeholderClick Calculate to get results

AUPHPerformance

The chart shows the growth of $10,000 invested in Aurinia Pharmaceuticals Inc. in Sep 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $35,415 for a total return of roughly 254.15%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-41.21%
-17.87%
AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (^GSPC)

AUPHReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-4.85%-9.18%
6M-41.97%-15.67%
YTD-68.26%-21.15%
1Y-67.93%-13.69%
5Y3.15%8.49%
10Y27.64%9.38%

AUPHMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-27.15%-26.17%0.65%-16.88%9.62%-10.90%-18.61%-10.02%-1.36%
202120.82%-16.22%-7.25%2.19%9.42%-10.74%4.63%20.06%35.93%49.48%-43.05%21.39%
2020-9.67%-4.37%-17.09%18.81%-7.95%2.39%-13.05%4.95%-0.67%6.45%-3.06%-9.01%
2019-7.62%7.14%-3.70%-5.08%5.02%1.54%-3.34%-9.75%-6.97%-8.99%63.37%155.16%
201817.00%-1.70%-0.38%1.16%11.05%-3.43%-3.91%3.14%19.00%-18.07%11.40%12.54%
201746.67%15.58%106.18%-4.50%-10.98%-1.76%2.94%2.85%-3.39%-6.22%-10.20%-14.20%
2016-19.03%18.50%22.78%0.34%1.71%-6.73%22.77%-42.95%55.15%0.66%0.33%-30.92%
2015-7.97%40.30%-7.23%-12.39%-8.12%-13.96%22.52%-8.11%-16.47%2.82%-13.70%-1.98%
201418.57%-27.67%7.94%8.15%0.00%29.79%-5.91%-15.91%-6.27%12.50%12.50%-10.12%
20130.00%5.11%0.00%0.00%-31.71%-10.22%34.48%-10.26%0.00%54.29%-2.66%26.36%
2012-51.22%0.00%380.00%-53.12%

AUPHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aurinia Pharmaceuticals Inc. Sharpe ratio is -0.76. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.76
-0.67
AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (^GSPC)

AUPHDividend History


Aurinia Pharmaceuticals Inc. doesn't pay dividends

AUPHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-78.05%
-21.65%
AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (^GSPC)

AUPHWorst Drawdowns

The table below shows the maximum drawdowns of the Aurinia Pharmaceuticals Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aurinia Pharmaceuticals Inc. is 79.87%, recorded on Sep 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.87%Nov 1, 2021214Sep 7, 2022
-69.79%Dec 3, 201213Jun 20, 2013140Mar 18, 2015153
-67.17%Mar 24, 2015208Jan 19, 2016284Mar 6, 2017492
-63.19%Mar 14, 2017652Oct 14, 201937Dec 5, 2019689
-53.4%Jan 3, 2020340May 10, 202188Sep 14, 2021428
-51.22%Sep 10, 20121Sep 10, 20121Nov 30, 20122
-19.96%Sep 28, 20217Oct 6, 202112Oct 22, 202119
-9.86%Sep 15, 20212Sep 16, 20213Sep 21, 20215
-5.51%Dec 30, 20191Dec 30, 20192Jan 2, 20203
-3.03%Dec 18, 20191Dec 18, 20193Dec 23, 20194

AUPHVolatility Chart

Current Aurinia Pharmaceuticals Inc. volatility is 40.80%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
40.80%
25.76%
AUPH (Aurinia Pharmaceuticals Inc.)
Benchmark (^GSPC)